Russian studies on transfer factor
- From: "Kevin Wilkinson" <kwilk@xxxxxxxxxxxxx>
- Date: Wed, 9 Nov 2005 20:25:46 -0600
The following is an exerpt from a book that was published by the Center of
MicroNutrientology in Moscow in 2004. It contains documents that reported
the results of a series of clinical studies done in Russian clinics and
endorsed by the Director of Medical Service and the Department of Treatment
Development for Health Recovery Resorts. It was presented to the Russian
Ministry of Health and Social Development. As a result of these findings,
Transfer Factor and Transfer Factor Plus were approved for use in Russian
Hospitals and Clinics as an immunomodulator in treating various diseases,
including cancer. The conclusion chapter stated:
"At present, the main courses of active non-specific immunotherapy are the
use of interferon inductors, stimulators of macrophagal activity, B and
T-lymphocytes, natural and recumbinant interferons with antiviral and
immunomodulating effects, as well endogenous regulators of immune reactions
such as interleukins and other cytokines. The use of natural endogenous
non-specific immunomodulators opens up new prospects of immunorehabilitation
in various infectious and somatic diseases. Generally, parenteral
administration of cytokines result in pronounced proinflammatory effects
leading to intensification of already hyper inflammatory reactions. In our
view the use of Transfer Factor, a unique and new generation
immunomodulators derived from bovine colostrum, is very promising in
countering this problem.
Experimental data and the results of studies carried out in different
clinics of this country have demonstrated the immunomodulating effects of
oral forms of transfer factors in various infectious. parasitic, and somatic
diseases. According to the results of these studies, TF produced
practically the same immunomodulating effect as did the most often used
interferons, cytokines, and other immunomodulators. In addition, oral use
of TF minimizes adverse reactions, gives optimal pharmacoeconomic effects
and helps to shorten the course of immunorehabilitation therepy."
.
- Follow-Ups:
- Re: Russian studies on transfer factor
- From: madiba
- Re: Russian studies on transfer factor
- Prev by Date: Re: American Cancer Society program uses carcinogenic products
- Next by Date: Re: American Cancer Society program uses carcinogenic products
- Previous by thread: Artificial Neural Networks Can Predict Clinical Outcomes Of Neuroblastoma Patients
- Next by thread: Re: Russian studies on transfer factor
- Index(es):